Virginia Retirement Systems Et Al Intercept Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	BUY	$9.17 - $19.29 $11,004 - $23,148	1,200 Added 2.19%	56,000 $619,000
Q1 2023 Jul 11, 2023	SELL	$12.53 - $21.71 $130,312 - $225,784	-10,400 Reduced 15.95%	54,800 $735,000
Q4 2022 May 17, 2023	BUY	$11.61 - $16.11 $101,007 - $140,157	8,700 Added 15.4%	65,200 $807 Million
Q3 2022 May 16, 2023	BUY	$12.21 - $19.7 $227,106 - $366,420	18,600 Added 49.08%	56,500 $788 Million
Q1 2022 Apr 21, 2022	BUY	$13.37 - $17.79 $24,066 - $32,022	1,800 Added 4.99%	37,900 $617,000

Q3 2021 Oct 21, 2021	BUY	$12.99 - $20.47 $77,940 - $122,820	6,000 Added 19.93%	36,100 $536,000
Q2 2021 Aug 13, 2021	BUY	$15.46 - $24.5 $188,612 - $298,900	12,200 Added 68.16%	30,100 $601,000
Q1 2021 Apr 30, 2021	BUY	$19.33 - $37.75 $102,448 - $200,075	5,300 Added 42.06%	17,900 $413,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $308,448 - $535,122	12,600 New	12,600 $311,000
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $175,905 - $240,480	-4,500 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$46.7 - $92.04 $28,020 - $55,224	-600 Reduced 11.76%	4,500 $216,000
Q1 2020 May 12, 2020	BUY	$48.35 - $118.68 $246,585 - $605,268	5,100 New	5,100 $321,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.